Citation Impact
Citing Papers
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Surgery for Nonobese Type 2 Diabetic Patients: An Interventional Study with Duodenal–Jejunal Exclusion
2009
The gut microbiota and host health: a new clinical frontier
2015 Standout
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
2012 Standout
The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease
2014
Microbiota in health and diseases
2022 Standout
The human fatty acid-binding protein family: Evolutionary divergences and functions
2011
Serum visfatin and vaspin levels in prepubertal children: effect of obesity and weight loss after behavior modifications on their secretion and relationship with glucose metabolism
2011
Non-alcoholic fatty liver disease – A global public health perspective
2018 Standout
Genetic Predisposition in NAFLD and NASH: Impact on Severity of Liver Disease and Response to Treatment
2013
Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome?
2007
FTO and Obesity: Mechanisms of Association
2014
Diabetes remission after bariatric surgery: is it just the incretins?
2011
Visfatin in juvenile obesity – the effect of obesity intervention and sex
2011
Metabolic benefits of dietary prebiotics in human subjects: a systematic review of randomised controlled trials
2013
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review
2011
Is Laparoscopic Duodenojejunal Bypass with Sleeve an Effective Alternative to Roux En Y Gastric Bypass in Morbidly Obese Patients: Preliminary Results of a Randomized Trial
2011
The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics
2020 Standout
Effects of synbiotic supplementation on insulin resistance in subjects with the metabolic syndrome: a randomised, double-blind, placebo-controlled pilot study
2014
Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics
2017 Standout
Candida in Solid Organ Transplant Recipients
2009
Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
2015 Standout
Evolution of Inflammation in Nonalcoholic Fatty Liver Disease: The Multiple Parallel Hits Hypothesis
2010 Standout
Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: Cosponsored by american association of clinical endocrinologists, The obesity society, and american society for metabolic & bariatric surgery*
2013 Standout
Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials
2012
Prophylaxis With Caspofungin for Invasive Fungal Infections in High-Risk Liver Transplant Recipients
2009
Dynamic transcriptomic m6A decoration: writers, erasers, readers and functions in RNA metabolism
2018 Standout
Treatment of NAFLD with diet, physical activity and exercise
2017
Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity?
2020
Effects of isolated soluble fiber supplementation on body weight, glycemia, and insulinemia in adults with overweight and obesity: a systematic review and meta-analysis of randomized controlled trials
2017
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: Is there a link?
2010
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
2016 Standout
Systematic review and meta‐analysis of clinical trials of the effects of low carbohydrate diets on cardiovascular risk factors
2012
Synbiotic supplementation in lean patients with non-alcoholic fatty liver disease: a pilot, randomised, double-blind, placebo-controlled, clinical trial
2017
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
Non-alcoholic fatty liver disease
2021 Standout
Metabolic Surgery for the Treatment of Type 2 Diabetes in Patients with BMI <35 kg/m2: An Integrative Review of Early Studies
2010
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Community-based lifestyle modification programme for non-alcoholic fatty liver disease: A randomized controlled trial
2013
Rates of and Factors Associated With Placebo Response in Trials of Pharmacotherapies for Nonalcoholic Steatohepatitis: Systematic Review and Meta-analysis
2018
The Gordian Knot of dysbiosis, obesity and NAFLD
2013
Mechanisms of Hepatic Fibrogenesis
2008 Standout
Effect of gastric bypass surgery on the incretins
2009
Role of the gut microbiota in nutrition and health
2018 Standout
Gut–liver axis, nutrition, and non-alcoholic fatty liver disease
2015
How to Manipulate the Microbiota: Prebiotics
2016
Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: The significance of dietary cholesterol
2008
Endocrine mechanisms mediating remission of diabetes after gastric bypass surgery
2009
Nutrigenetics of cholesterol metabolism: observational and dietary intervention studies in the postgenomic era
2015
PPARγ signaling and metabolism: the good, the bad and the future
2013 Standout
Influence of diet on the gut microbiome and implications for human health
2017 Standout
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2012 Standout
Orlistat for overweight subjects with nonalcoholic steatohepatitis
2008
The role of adiponectin in the pathogenesis and treatment of non‐alcoholic fatty liver disease
2009
Antifungal prophylaxis in liver transplant recipients
2009
Differential Significance of Plasma Visfatin Concentrations according to Adiposity in Children and Adolescents
2013 Standout
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Efficacy of Probiotics and Synbiotics in Patients with Nonalcoholic Fatty Liver Disease: A Meta-Analysis
2019
Laser desorption time-of-flight mass spectrometric analysis of transferrin precipitated with antiserum: A unique simple method to identify molecular weight variants
1994 StandoutNobel
Molecular Characterization of the Fecal Microbiota in Patients with Nonalcoholic Steatohepatitis – A Longitudinal Study
2013
NAFLD: A multisystem disease
2015 Standout
Genetics and epigenetics in obesity
2018
Adipokines in liver diseases #
2009
European Guidelines for Obesity Management in Adults
2015 Standout
Gut microbiome–targeted therapies in nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression
2019
Impact of Gastrointestinal Surgery on Cardiometabolic Risk
2012
Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease
2018
Effects of probiotics on nonalcoholic fatty liver disease: A meta-analysis
2013
Immunometabolic Regulation of Vascular Redox State: The Role of Adipose Tissue
2017
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Diet and exercise in NAFLD/NASH: Beyond the obvious
2021
Prospective histopathologic evaluation of lifestyle modification in nonalcoholic fatty liver disease: a randomized trial
2013
AASLD guidelines for the treatment of hepatocellular carcinoma
2017 Standout
Clinical practice guidelines for antimicrobial prophylaxis in surgery
2013 Standout
Tirzepatide Once Weekly for the Treatment of Obesity
2022 Standout
Nonalcoholic Fatty Liver Disease: Pathology and Pathogenesis
2010
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Effects of Probiotics, Prebiotics, and Synbiotics on Human Health
2017 Standout
Current treatment of non‐alcoholic fatty liver disease
2008
Can Roux-en-Y gastric bypass provide a lifelong solution for diabetes mellitus?
2009
Adipokines and the cardiovascular system: mechanisms mediating health and disease
2012
Pharmacological Approaches in the Treatment and Maintenance of Weight Loss
2016
Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysis
2017 Standout
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
A high-fat, ketogenic diet causes hepatic insulin resistance in mice, despite increasing energy expenditure and preventing weight gain
2010
Adipokines in Nonalcoholic Steatohepatitis: From Pathogenesis to Implications in Diagnosis and Therapy
2009
Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity
2016 Standout
American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines For Medical Care of Patients with Obesity
2016
Pathophysiology of Type 2 Diabetes Mellitus
2020 Standout
Once-Weekly Semaglutide in Adults with Overweight or Obesity
2021 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Review article: emerging anti‐fibrotic therapies in the treatment of non‐alcoholic steatohepatitis
2016
Biochemical Characteristics and Diagnosis of the Carbohydrate‐deficient Glycoprotein Syndrome
1991
Impact of a Mediterranean diet on hepatic and metabolic outcomes in non‐alcoholic fatty liver disease: The MEDINA randomised controlled trial
2022
Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.
2011 StandoutNobel
Prosthetic Joint Infection
2014 Standout
Lethal mitochondrial cardiomyopathy in a hypomorphic Med30 mouse mutant is ameliorated by ketogenic diet
2011 StandoutNobel
Metabolic Surgery to Treat Type 2 Diabetes: Clinical Outcomes and Mechanisms of Action
2010
Surgery for weight loss in adults
2014 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Arylfluorosulfates Inactivate Intracellular Lipid Binding Protein(s) through Chemoselective SuFEx Reaction with a Binding Site Tyr Residue
2016 StandoutNobel
Nonalcoholic Fatty Liver Disease
2015 Standout
Obesity: global epidemiology and pathogenesis
2019 Standout
Hidden Killers: Human Fungal Infections
2012 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Works of R. Conde being referenced
Evaluation of Weight Loss and Adipocytokine Levels after Two Hypocaloric Diets with Different Macronutrient Distribution in Obese Subjects with the rs6923761 Gene Variant of Glucagon-Like Peptide 1 Receptor
2013
Modulation of Adipocytokines Response and Weight Loss Secondary to a Hypocaloric Diet in Obese Patients by -55CT Polymorphism of UCP3 Gene
2008
Influence of Insulin Resistance and Adipokines in the Grade of Steatosis of Nonalcoholic Fatty Liver Disease
2007
Polymorphism Ala54Thr of Fatty Acid-Binding Protein 2: Allelic Frequencies and Influence on Cardiovascular Risk Factors in a Multicenter Study of Castilla y Leon
2010
Metabolic syndrome and ALA54THR polymorphism of fatty acid–binding protein 2 in obese patients
2010
Tumor-Associated Trypsin Inhibitor (Tati) in Patients with Colorectal Carcinoma. A Critical Comparison with Cea
1991
Serum Visfatin Concentrations Are Related to Dietary Intake in Obese Patients
2010
Effects of a Low-Fat versus a Low-Carbohydrate Diet on Adipocytokines in Obese Adults
2007
Influence of Trp64Arg Polymorphism of Beta 3-Adrenoreceptor Gene on Insulin Resistance, Adipocytokines and Weight Loss Secondary to Two Hypocaloric Diets
2009
Resistin Levels in Morbid Obese Patients Following the Biliopancreatic Diversion Surgery
2011
Influence of Ala54Thr polymorphism of fatty acid-binding protein 2 on weight loss and insulin levels secondary to two hypocaloric diets: A randomized clinical trial
2008
Decreased Basal Levels of Glucagon-Like Peptide-1 after Weight Loss in Obese Subjects
2007
Effects of C358A missense polymorphism of the degrading enzyme fatty acid amide hydrolase on weight loss, adipocytokines, and insulin resistance after 2 hypocaloric diets
2010
Influence of Visfatin on Histopathological Changes of Non-alcoholic Fatty Liver Disease
2008
Effect of a hypocaloric diet in transaminases in nonalcoholic fatty liver disease and obese patients, relation with insulin resistance
2007
Lack of Association of –55CT Polymorphism of UCP3 Gene with Fat Distribution in Obese Patients
2007
Effect of a hypocaloric diet on serum visfatin in obese non-diabetic patients
2008
The effects of duodenal-jejunal exclusion on hormonal regulation of glucose metabolism in Goto-Kakizaki rats
2007
Safety of Percutaneous Ethanol Injection as Neoadjuvant Therapy for Hepatocellular Carcinoma in Waiting List Liver Transplant Candidates
2005
Double blind randomized clinical trial controlled by placebo with an alpha linoleic acid and prebiotic enriched cookie on risk cardiovascular factor in obese patients.
2012
Modulation of Insulin Concentrations and Metabolic Parameters in Obese Patients by −55CT Polymorphism of the UCP3 Gene Secondary to Two Hypocaloric Diets
2008
Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial.
2011
[Randomized clinical trial with a inulin enriched cookie on risk cardiovascular factor in obese patients].
2010
Role of -55CT polymorphism of UCP3 gene on non alcoholic fatty liver disease and insulin resistance in patients with obesity.
2011
Effect of two different hypocaloric diets in transaminases and insulin resistance in nonalcoholic fatty liver disease and obese patients.
2011
Prospective Interventional Study to Evaluate the Efficacy and Safety of Liposomal Amphotericin B as Prophylaxis of Fungal Infections in High-Risk Liver Transplant Recipients
2005
Evaluation of weight loss and adipocytokines levels after two hypocaloric diets with different macronutrient distribution in obese subjects with rs9939609 gene variant
2012
Influence of insulin resistance in obese patients on elevated serum alanine aminotransferase.
2007
The rs9939609 Gene Variant in FTO Modified the Metabolic Response of Weight Loss After a 3-Month Intervention With a Hypocaloric Diet
2013
Serum visfatin levels and metabolic syndrome criteria in obese female subjects
2013
Circulating adipocytokines in morbid obese patients, relation with cardiovascular risk factors and anthropometric parameters.
2011